Using Patient Risk Factors to Identify Whether Carbapenem-Resistant Enterobacteriaceae Infections Are Caused by Carbapenemase-Producing Organisms-Reference-Cited by-同舟云学术

Using Patient Risk Factors to Identify Whether Carbapenem-Resistant Enterobacteriaceae Infections Are Caused by Carbapenemase-Producing Organisms

Published:2018-05-01 Issue:5 Volume:5 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Simner Patricia J¹,Goodman Katherine E²,Carroll Karen C¹,Harris Anthony D³,Han Jennifer H⁴,Tamma Pranita D⁵

Affiliation:

1. Division of Medical Microbiology, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland

2. Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

3. Department of Epidemiology and Public Health, The University of Maryland School of Medicine, Baltimore, Maryland

4. Division of Infectious Diseases, Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

5. Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland

Abstract

Abstract Evaluating all inpatient carbapenem-resistant Enterobacteriaceae (CRE) infections over a 1-year period, 47% were caused by carbapenemase-producing (CP) organisms. Compared with non-CP-CRE patients, patients with CP-CRE had an 18-fold greater odds of a recent stay in a foreign health care facility and a 3-fold greater odds of transfer from a post–acute care facility.

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/5/5/ofy094/33591386/ofy094.pdf

Reference19 articles.

1. The global epidemiology of carbapenemase-producing Enterobacteriaceae;van Duin;Virulence,2017

2. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE);Goodman;Expert Rev Anti Infect Ther,2016

3. Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia;Tamma;Clin Infect Dis,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbapenem-resistant Enterobacterales in Children at 18 US Health Care System Study Sites: Clinical and Molecular Epidemiology From a Prospective Multicenter Cohort Study;Open Forum Infectious Diseases;2024-01-08

2. Multicentre genetic diversity study of carbapenem-resistant Enterobacterales: predominance of untypeable pUVA-like blaKPC bearing plasmids;JAC-Antimicrobial Resistance;2023-05-03

3. Predictive score for patients with carbapenemase-producing enterobacterales colonization upon admission in a tertiary care hospital in an endemic area;Journal of Antimicrobial Chemotherapy;2022-10-07

4. Combination antibiotic therapy for treatment of a patient with infected prosthesis and peri-prosthetic abscess due to Klebsiella pneumoniae harboring New Delhi Metallo (NDM) beta-lactamase;IDCases;2022

5. Increased carbapenemase testing following implementation of national VA guidelines for carbapenem-resistant Enterobacterales (CRE);Antimicrobial Stewardship and Healthcare Epidemiology;2022